Fatty acid oxidation disorders: maternal health and neonatal outcomes

Seminars in Fetal and Neonatal Medicine

Volumn 15, Issue 3, 2010, Pages 122-128

  Rector, R Scott ^a   Ibdah, Jamal A ^a,b  

^a UNIVERSITY OF MISSOURI   (United States)

^b University of Missouri   (United States)

Author keywords

Acute fatty liver of pregnancy; HELLP syndrome; Inborn errors of metabolism; LCHAD deficiency; Mitochondrial fatty acid oxidation; Mitochondrial trifunctional protein

Indexed keywords

ACYLCARNITINE CARNITINE TRANSLOCASE; CARNITINE; CARNITINE PALMITOYLTRANSFERASE; CARRIER PROTEIN; GLUCOSE; LONG CHAIN ACYL COENZYME A DEHYDROGENASE; MEDIUM CHAIN ACYL COENZYME A DEHYDROGENASE; UNCLASSIFIED DRUG;

ACUTE FATTY LIVER OF PREGNANCY; ARTICLE; CARNITINE ACYLCARNITINE TRANSLOCASE DEFICIENCY; CARNITINE PALMITOYLTRANSFERASE I DEFICIENCY; CARNITINE PALMITOYLTRANSFERASE II DEFICIENCY; CHILD HEALTH; CLINICAL FEATURE; ECLAMPSIA; ENZYME DEFICIENCY; FATTY ACID OXIDATION; GENE MUTATION; GENETIC DISORDER; HELLP SYNDROME; HUMAN; INBORN ERROR OF METABOLISM; LABORATORY TEST; LIVER DISEASE; LONG CHAIN 3 HYDROXYACYL COENZYME A DEHYDROGENASE DEFICIENCY; LONG CHAIN ACYL COENZYME A DEHYDROGENASE DEFICIENCY; LOW FAT DIET; MATERNAL WELFARE; MEDIUM CHAIN ACYL COENZYME A DEHYDROGENASE DEFICIENCY; MITOCHONDRIAL RESPIRATION; MITOCHONDRIAL TRIFUNCTIONAL DEFICIENCY; NEWBORN SCREENING; PREGNANCY OUTCOME; PRENATAL DIAGNOSIS; SUDDEN INFANT DEATH SYNDROME; VERY LONG CHAIN ACYL COENZYME A DEHYDROGENASE DEFICIENCY;

BRAIN DISEASES, METABOLIC, INBORN; FATTY ACIDS; FEMALE; HUMANS; INFANT, NEWBORN; LIPID METABOLISM, INBORN ERRORS; MITOCHONDRIAL DISEASES; NEONATAL SCREENING; OXIDATION-REDUCTION; PREGNANCY;

EID: 77953289907     PISSN: 1744165X     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.siny.2009.10.006     Document Type: Article

References (55)

1. Rinaldo P., Matern D., and Bennett M.J. Fatty acid oxidation disorders. Annu Rev Physiol 64 (2002) 477-502
2. Zytkovicz T.H., Fitzgerald E.F., Marsden D., et al. Tandem mass spectrometric analysis for amino, organic, and fatty acid disorders in newborn dried blood spots: a two-year summary from the New England Newborn Screening Program. Clin Chem 47 (2001) 1945-1955
3. Eaton S., Bartlett K., and Pourfarzam M. Mammalian mitochondrial beta-oxidation. Biochem J 320 Pt 2 (1996) 345-357
4. McGarry J.D., and Foster D.W. Regulation of hepatic fatty acid oxidation and ketone body production. Annu Rev Biochem 49 (1980) 395-420
5. Stanley C.A., and Baker L. Hyperinsulinism in infancy: diagnosis by demonstration of abnormal response to fasting hypoglycemia. Pediatrics 57 (1976) 702-711
6. Kamijo T., Wanders R.J., Saudubray J.M., Aoyama T., Komiyama A., and Hashimoto T. Mitochondrial trifunctional protein deficiency. Catalytic heterogeneity of the mutant enzyme in two patients. J Clin Invest 93 (1994) 1740-1747
7. Carpenter K., Pollitt R.J., and Middleton B. Human liver long-chain 3-hydroxyacyl-coenzyme A dehydrogenase is a multifunctional membrane-bound beta-oxidation enzyme of mitochondria. Biochem Biophys Res Commun 183 (1992) 443-448
8. DiMauro S., and DiMauro P.M. Muscle carnitine palmityltransferase deficiency and myoglobinuria. Science 182 (1973) 929-931
9. Tanaka K., Yokota I., Coates P.M., et al. Mutations in the medium chain acyl-CoA dehydrogenase (MCAD) gene. Hum Mutat 1 (1992) 271-279
10. Wanders R.J., Duran M., Ijlst L., et al. Sudden infant death and long-chain 3-hydroxyacyl-CoA dehydrogenase. Lancet 2 (1989) 52-53
11. Wanders R.J., Ijlst L., Poggi F., et al. Human trifunctional protein deficiency: a new disorder of mitochondrial fatty acid beta-oxidation. Biochem Biophys Res Commun 188 (1992) 1139-1145
12. Vianey-Liaud C., Divry P., Gregersen N., and Mathieu M. The inborn errors of mitochondrial fatty acid oxidation. J Inherit Metab Dis 10 Suppl.1 (1987) 159-200
13. Gregersen N., Bross P., and Andresen B.S. Genetic defects in fatty acid beta-oxidation and acyl-CoA dehydrogenases. Molecular pathogenesis and genotype-phenotype relationships. Eur J Biochem 271 (2004) 470-482
14. Innes A.M., Seargeant L.E., Balachandra K., et al. Hepatic carnitine palmitoyltransferase I deficiency presenting as maternal illness in pregnancy. Pediatr Res 47 (2000) 43-45
15. Fingerhut R., Roschinger W., Muntau A.C., et al. Hepatic carnitine palmitoyltransferase I deficiency: acylcarnitine profiles in blood spots are highly specific. Clin Chem 47 (2001) 1763-1768
16. Thuillier L., Rostane H., Droin V., et al. Correlation between genotype, metabolic data, and clinical presentation in carnitine palmitoyltransferase 2 (CPT2) deficiency. Hum Mutat 21 (2003) 493-501
17. Ibdah J.A., Bennett M.J., Rinaldo P., et al. A fetal fatty-acid oxidation disorder as a cause of liver disease in pregnant women. N Engl J Med 340 (1999) 1723-1731
18. Ibdah J.A., Tein I., Dionisi-Vici C., et al. Mild trifunctional protein deficiency is associated with progressive neuropathy and myopathy and suggests a novel genotype-phenotype correlation. J Clin Invest 102 (1998) 1193-1199
19. Yang Z., Zhao Y., Bennett M.J., Strauss A.W., and Ibdah J.A. Fetal genotypes and pregnancy outcomes in 35 families with mitochondrial trifunctional protein mutations. Am J Obstet Gynecol 187 (2002) 715-720
20. Sims H.F., Brackett J.C., Powell C.K., et al. The molecular basis of pediatric long chain 3-hydroxyacyl-CoA dehydrogenase deficiency associated with maternal acute fatty liver of pregnancy. Proc Natl Acad Sci USA 92 (1995) 841-845
21. Ijlst L., Wanders R.J., Ushikubo S., Kamijo T., and Hashimoto T. Molecular basis of long-chain 3-hydroxyacyl-CoA dehydrogenase deficiency: identification of the major disease-causing mutation in the alpha-subunit of the mitochondrial trifunctional protein. Biochim Biophys Acta 1215 (1994) 347-350
22. Yamaguchi S., Indo Y., Coates P.M., Hashimoto T., and Tanaka K. Identification of very-long-chain acyl-CoA dehydrogenase deficiency in three patients previously diagnosed with long-chain acyl-CoA dehydrogenase deficiency. Pediatr Res 34 (1993) 111-113
23. Riely C.A. Acute fatty liver of pregnancy. Semin Liver Dis 7 (1987) 47-54
24. Knox T.A., and Olans L.B. Liver disease in pregnancy. N Engl J Med 335 (1996) 569-576
25. Barton J.R., Riely C.A., Adamec T.A., Shanklin D.R., Khoury A.D., and Sibai B.M. Hepatic histopathologic condition does not correlate with laboratory abnormalities in HELLP syndrome (hemolysis, elevated liver enzymes, and low platelet count). Am J Obstet Gynecol 167 (1992) 1538-1543
26. Minakami H., Oka N., Sato T., Tamada T., Yasuda Y., and Hirota N. Preeclampsia: a microvesicular fat disease of the liver?. Am J Obstet Gynecol 159 (1988) 1043-1047
27. Dani R., Mendes G.S., Medeiros Jde L., Peret F.J., and Nunes A. Study of the liver changes occurring in preeclampsia and their possible pathogenetic connection with acute fatty liver of pregnancy. Am J Gastroenterol 91 (1996) 292-294
28. Riely C.A., Latham P.S., Romero R., and Duffy T.P. Acute fatty liver of pregnancy. A reassessment based on observations in nine patients. Ann Intern Med 106 (1987) 703-706
29. Sibai B.M., Ramadan M.K., Usta I., Salama M., Mercer B.M., and Friedman S.A. Maternal morbidity and mortality in 442 pregnancies with hemolysis, elevated liver enzymes, and low platelets (HELLP syndrome). Am J Obstet Gynecol 169 (1993) 1000-1006
30. Usta I.M., Barton J.R., Amon E.A., Gonzalez A., and Sibai B.M. Acute fatty liver of pregnancy: an experience in the diagnosis and management of fourteen cases. Am J Obstet Gynecol 171 (1994) 1342-1347
31. Burroughs A.K., Seong N.H., Dojcinov D.M., Scheuer P.J., and Sherlock S.V. Idiopathic acute fatty liver of pregnancy in 12 patients. Q J Med 51 (1982) 481-497
32. Yang Z., Yamada J., Zhao Y., Strauss A.W., and Ibdah J.A. Prospective screening for pediatric mitochondrial trifunctional protein defects in pregnancies complicated by liver disease. J Am Med Assoc 288 (2002) 2163-2166
33. Ibdah J.A., Yang Z., and Bennett M.J. Liver disease in pregnancy and fetal fatty acid oxidation defects. Mol Genet Metab 71 (2000) 182-189
34. Schoeman M.N., Batey R.G., and Wilcken B. Recurrent acute fatty liver of pregnancy associated with a fatty-acid oxidation defect in the offspring. Gastroenterology 100 (1991) 544-548
35. Wilcken B., Leung K.C., Hammond J., Kamath R., and Leonard J.V. Pregnancy and fetal long-chain 3-hydroxyacyl coenzyme A dehydrogenase deficiency. Lancet 341 (1993) 407-408
36. Treem W.R., Rinaldo P., Hale D.E., et al. Acute fatty liver of pregnancy and long-chain 3-hydroxyacyl-coenzyme A dehydrogenase deficiency. Hepatology 19 (1994) 339-345
37. Ibdah J.A., Zhao Y., Viola J., Gibson B., Bennett M.J., and Strauss A.W. Molecular prenatal diagnosis in families with fetal mitochondrial trifunctional protein mutations. J Pediatr 138 (2001) 396-399
38. Mathews T.J., Menacker F., and MacDorman M.F. Infant mortality statistics from the 2000 period linked birth/infant death data set. Natl Vital Stat Rep 50 (2002) 1-28
39. Yang Z., Lantz P.E., and Ibdah J.A. Post-mortem analysis for two prevalent beta-oxidation mutations in sudden infant death. Pediatr Int 49 (2007) 883-887
40. Bonnet D., Martin D., Pascale De L., et al. Arrhythmias and conduction defects as presenting symptoms of fatty acid oxidation disorders in children. Circulation 100 (1999) 2248-2253
41. Bennett M.J. The laboratory diagnosis of inborn errors of mitochondrial fatty acid oxidation. Ann Clin Biochem 27 Pt 6 (1990) 519-531
42. Millington D.S., Terada N., Chace D.H., et al. The role of tandem mass spectrometry in the diagnosis of fatty acid oxidation disorders. Prog Clin Biol Res 375 (1992) 339-354
43. Costa C.G., Dorland L., Holwerda U., et al. Simultaneous analysis of plasma free fatty acids and their 3-hydroxy analogs in fatty acid beta-oxidation disorders. Clin Chem 44 (1998) 463-471
44. Jones P.M., Quinn R., Fennessey P.V., et al. Improved stable isotope dilution-gas chromatography-mass spectrometry method for serum or plasma free 3-hydroxy-fatty acids and its utility for the study of disorders of mitochondrial fatty acid beta-oxidation. Clin Chem 46 (2000) 149-155
45. Lagerstedt S.A., Hinrichs D.R., Batt S.M., Magera M.J., Rinaldo P., and McConnell J.P. Quantitative determination of plasma c8-c26 total fatty acids for the biochemical diagnosis of nutritional and metabolic disorders. Mol Genet Metab 73 (2001) 38-45
46. Bennett M.J., Allison F., Lowther G.W., et al. Prenatal diagnosis of medium-chain acyl-coenzyme A dehydrogenase deficiency. Prenat Diagn 7 (1987) 135-141
47. Guthrie R., and Susi A. A simple phenylalanine method for detecting phenylketonuria in large populations of newborn infants. Pediatrics 32 (1963) 338-343
48. Rinaldo P., and Matern D. Disorders of fatty acid transport and mitochondrial oxidation: challenges and dilemmas of metabolic evaluation. Genet Med 2 (2000) 338-344
49. Millington D.S., Kodo N., Norwood D.L., and Roe C.R. Tandem mass spectrometry: a new method for acylcarnitine profiling with potential for neonatal screening for inborn errors of metabolism. J Inherit Metab Dis 13 (1990) 321-324
50. Chace D.H., DiPerna J.C., Mitchell B.L., Sgroi B., Hofman L.F., and Naylor E.W. Electrospray tandem mass spectrometry for analysis of acylcarnitines in dried postmortem blood specimens collected at autopsy from infants with unexplained cause of death. Clin Chem 47 (2001) 1166-1182
51. Naylor E.W., and Chace D.H. Automated tandem mass spectrometry for mass newborn screening for disorders in fatty acid, organic acid, and amino acid metabolism. J Child Neurol 14 Suppl.1 (1999) S4-S8
52. Schulze A., Lindner M., Kohlmuller D., Olgemoller K., Mayatepek E., and Hoffmann G.F. Expanded newborn screening for inborn errors of metabolism by electrospray ionization-tandem mass spectrometry: results, outcome, and implications. Pediatrics 111 (2003) 1399-1406
53. Schoen E.J., Baker J.C., Colby C.J., and To T.T. Cost-benefit analysis of universal tandem mass spectrometry for newborn screening. Pediatrics 110 (2002) 781-786
54. Lamhonwah A.M., Olpin S.E., Pollitt R.J., et al. Novel OCTN2 mutations: no genotype-phenotype correlations: early carnitine therapy prevents cardiomyopathy. Am J Med Genet 111 (2002) 271-284
55. Gillingham M.B., Connor W.E., Matern D., et al. Optimal dietary therapy of long-chain 3-hydroxyacyl-CoA dehydrogenase deficiency. Mol Genet Metab 79 (2003) 114-123